Skip to main content
Erschienen in: Esophagus 1/2016

01.01.2016 | Original Article

Association of interleukin-1B gene polymorphisms at site 511 with gastroesophageal reflux disease: a meta-analysis

verfasst von: Minmin Xue, Sujuan Zhang, Jia Li, Wei Li, Dongxu Wang

Erschienen in: Esophagus | Ausgabe 1/2016

Einloggen, um Zugang zu erhalten

Abstract

Objectives

Multiple factors including genetic and environmental factors play a role in the pathogenesis of gastroesophageal reflux disease (GERD). The objective of this study was to quantitatively evaluate the association between Interleukin-1B-511 gene polymorphism and GERD susceptibility.

Methodology

Medline, CBM, VIP, CNKI, and Wanfang database were searched up to July 2014. Two reviewers independently assessed abstract of those searched articles. Finally, eight studies fulfilled our inclusion and exclusion criterion. Data about IL-1B-511 gene polymorphism and GERD condition were extracted and combined using the random-effect model.

Results

A total of 1199 GERD patients and 1428 controls were included in current meta-analysis. The combined results showed there were no association of IL-1B-511 gene polymorphism and GERD susceptibility (allele T vs C OR = 0.98, 95 % CI 0.79–1.23; genotype TT&TC vs CC OR = 0.91, 95 % CI 0.64–1.28).

Conclusion

This meta-analysis suggested that the genetic polymorphism of IL-1B-511 might not be associated with susceptibility of GERD.
Literatur
1.
Zurück zum Zitat Katz PO, Gerson LB, Vela MF. Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol. 2013;108(3):308–28 quiz 329.PubMedCrossRef Katz PO, Gerson LB, Vela MF. Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol. 2013;108(3):308–28 quiz 329.PubMedCrossRef
2.
Zurück zum Zitat French-Belgian Consensus Conference on Adult Gastro-oesophageal Reflux Disease ‘Diagnosis and Treatment’: report of a meeting held in Paris, France, on 21–22 January 1999. The Jury of the consensus conference. Eur J Gastroenterol Hepatol. 2000;12(1):129–37. French-Belgian Consensus Conference on Adult Gastro-oesophageal Reflux Disease ‘Diagnosis and Treatment’: report of a meeting held in Paris, France, on 21–22 January 1999. The Jury of the consensus conference. Eur J Gastroenterol Hepatol. 2000;12(1):129–37.
3.
Zurück zum Zitat Armstrong D, Marshall JK, Chiba N, Enns R, Fallone CA, Fass R, et al. Canadian Consensus Conference on the management of gastroesophageal reflux disease in adults—update 2004. Can J Gastroenterol. 2005;19((1):15–35.PubMed Armstrong D, Marshall JK, Chiba N, Enns R, Fallone CA, Fass R, et al. Canadian Consensus Conference on the management of gastroesophageal reflux disease in adults—update 2004. Can J Gastroenterol. 2005;19((1):15–35.PubMed
4.
Zurück zum Zitat Katelaris P, Holloway R, Talley N, Gotley D, WilliamsJ S. Dent, Gastro-oesophageal reflux disease in adults: Guidelines for clinicians. J Gastroenterol Hepatol. 2002;17(8):825–33.PubMedCrossRef Katelaris P, Holloway R, Talley N, Gotley D, WilliamsJ S. Dent, Gastro-oesophageal reflux disease in adults: Guidelines for clinicians. J Gastroenterol Hepatol. 2002;17(8):825–33.PubMedCrossRef
5.
Zurück zum Zitat Koop H, Schepp W, Muller-Lissner S, Madisch A, Micklefield G, Messmann H, et al. Consensus conference of the DGVS on gastroesophageal reflux. Z Gastroenterol. 2005;43(2):163–4.PubMedCrossRef Koop H, Schepp W, Muller-Lissner S, Madisch A, Micklefield G, Messmann H, et al. Consensus conference of the DGVS on gastroesophageal reflux. Z Gastroenterol. 2005;43(2):163–4.PubMedCrossRef
6.
Zurück zum Zitat Moraes-Filho J, Cecconello I, Gama-Rodrigues J, Castro L, Henry MA, Meneghelli UG, et al. Brazilian consensus on gastroesophageal reflux disease: proposals for assessment, classification, and management. Am J Gastroenterol. 2002;97(2):241–8.PubMedCrossRef Moraes-Filho J, Cecconello I, Gama-Rodrigues J, Castro L, Henry MA, Meneghelli UG, et al. Brazilian consensus on gastroesophageal reflux disease: proposals for assessment, classification, and management. Am J Gastroenterol. 2002;97(2):241–8.PubMedCrossRef
7.
Zurück zum Zitat Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006;101(8):1900–20 quiz 1943.PubMedCrossRef Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006;101(8):1900–20 quiz 1943.PubMedCrossRef
8.
Zurück zum Zitat Fock KM, Talley N, Hunt R, Fass R, Nandurkar S, Lam SK, et al. Report of the Asia-Pacific consensus on the management of gastroesophageal reflux disease. J Gastroenterol Hepatol. 2004;19(4):357–67.PubMedCrossRef Fock KM, Talley N, Hunt R, Fass R, Nandurkar S, Lam SK, et al. Report of the Asia-Pacific consensus on the management of gastroesophageal reflux disease. J Gastroenterol Hepatol. 2004;19(4):357–67.PubMedCrossRef
9.
Zurück zum Zitat Ghoshal UCD. Chourasia, gastroesophageal reflux disease and helicobacter pylori: what may be the relationship? J Neurogastroenterol Motil. 2010;16(3):243–50.PubMedPubMedCentralCrossRef Ghoshal UCD. Chourasia, gastroesophageal reflux disease and helicobacter pylori: what may be the relationship? J Neurogastroenterol Motil. 2010;16(3):243–50.PubMedPubMedCentralCrossRef
10.
Zurück zum Zitat Holtmann G, AdamT B. Liebregts, Review article: the patient with gastro-oesophageal reflux disease—lifestyle advice and medication. Aliment Pharmacol Ther. 2004;20(Suppl 8):24–7.PubMedCrossRef Holtmann G, AdamT B. Liebregts, Review article: the patient with gastro-oesophageal reflux disease—lifestyle advice and medication. Aliment Pharmacol Ther. 2004;20(Suppl 8):24–7.PubMedCrossRef
11.
Zurück zum Zitat Cameron AJ, Lagergren J, Henriksson C, Nyren O, Locke GR 3rd, Pedersen NL. Gastroesophageal reflux disease in monozygotic and dizygotic twins. Gastroenterology. 2002;122(1):55–9.PubMedCrossRef Cameron AJ, Lagergren J, Henriksson C, Nyren O, Locke GR 3rd, Pedersen NL. Gastroesophageal reflux disease in monozygotic and dizygotic twins. Gastroenterology. 2002;122(1):55–9.PubMedCrossRef
12.
13.
Zurück zum Zitat Dinarello CA. Biologic basis for interleukin-1 in disease. Blood. 1996;87(6):2095–147.PubMed Dinarello CA. Biologic basis for interleukin-1 in disease. Blood. 1996;87(6):2095–147.PubMed
15.
Zurück zum Zitat El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature. 2000;404(6776):398–402.PubMedCrossRef El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature. 2000;404(6776):398–402.PubMedCrossRef
16.
Zurück zum Zitat Kanemoto K, Kawasaki J, Miyamoto T, ObayashiM H. Nishimura, Interleukin (IL)1beta, IL-1alpha, and IL-1 receptor antagonist gene polymorphisms in patients with temporal lobe epilepsy. Ann Neurol. 2000;47(5):571–4.PubMedCrossRef Kanemoto K, Kawasaki J, Miyamoto T, ObayashiM H. Nishimura, Interleukin (IL)1beta, IL-1alpha, and IL-1 receptor antagonist gene polymorphisms in patients with temporal lobe epilepsy. Ann Neurol. 2000;47(5):571–4.PubMedCrossRef
17.
Zurück zum Zitat Hwang IR, Kodama T, Kikuchi S, Sakai K, Peterson LE, Graham DY, et al. Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1beta production in Helicobacter pylori infection. Gastroenterology. 2002;123(6):1793–803.PubMedCrossRef Hwang IR, Kodama T, Kikuchi S, Sakai K, Peterson LE, Graham DY, et al. Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1beta production in Helicobacter pylori infection. Gastroenterology. 2002;123(6):1793–803.PubMedCrossRef
18.
Zurück zum Zitat Kauffman MA, Moron DG, Consalvo D, BelloS R. Kochen, Association study between interleukin 1 beta gene and epileptic disorders: a HuGe review and meta-analysis. Genet Med. 2008;10(2):83–8.PubMedCrossRef Kauffman MA, Moron DG, Consalvo D, BelloS R. Kochen, Association study between interleukin 1 beta gene and epileptic disorders: a HuGe review and meta-analysis. Genet Med. 2008;10(2):83–8.PubMedCrossRef
19.
Zurück zum Zitat Sugimoto M, FurutaY T. Yamaoka, Influence of inflammatory cytokine polymorphisms on eradication rates of Helicobacter pylori. J Gastroenterol Hepatol. 2009;24(11):1725–32.PubMedPubMedCentralCrossRef Sugimoto M, FurutaY T. Yamaoka, Influence of inflammatory cytokine polymorphisms on eradication rates of Helicobacter pylori. J Gastroenterol Hepatol. 2009;24(11):1725–32.PubMedPubMedCentralCrossRef
20.
Zurück zum Zitat Chourasia D, Achyut BR, Tripathi S, Mittal B, Mittal RD, Ghoshal UC. Genotypic and functional roles of IL-1B and IL-1RN on the risk of gastroesophageal reflux disease: the presence of IL-1B-511*T/IL-1RN*1 (T1) haplotype may protect against the disease. Am J Gastroenterol. 2009;104(11):2704–13.PubMedCrossRef Chourasia D, Achyut BR, Tripathi S, Mittal B, Mittal RD, Ghoshal UC. Genotypic and functional roles of IL-1B and IL-1RN on the risk of gastroesophageal reflux disease: the presence of IL-1B-511*T/IL-1RN*1 (T1) haplotype may protect against the disease. Am J Gastroenterol. 2009;104(11):2704–13.PubMedCrossRef
21.
Zurück zum Zitat Kim JJ, Kim N, Hwang S, Kim JY, Choi YJ, Lee DH, et al. Relationship of interleukin-1beta levels and gastroesophageal reflux disease in Korea. J Gastroenterol Hepatol. 2013;28(1):90–8.PubMedCrossRef Kim JJ, Kim N, Hwang S, Kim JY, Choi YJ, Lee DH, et al. Relationship of interleukin-1beta levels and gastroesophageal reflux disease in Korea. J Gastroenterol Hepatol. 2013;28(1):90–8.PubMedCrossRef
22.
Zurück zum Zitat Cheng HH, Chang CS, Wang HJ, Wang WC. Interleukin-1beta and -10 polymorphisms influence erosive reflux esophagitis and gastritis in Taiwanese patients. J Gastroenterol Hepatol. 2010;25(8):1443–51.PubMedCrossRef Cheng HH, Chang CS, Wang HJ, Wang WC. Interleukin-1beta and -10 polymorphisms influence erosive reflux esophagitis and gastritis in Taiwanese patients. J Gastroenterol Hepatol. 2010;25(8):1443–51.PubMedCrossRef
23.
Zurück zum Zitat Izakovicova Holla L, Borilova Linhartova P, Hrdlickova B, Marek F, Dolina J, Rihak V, et al. Haplotypes of the IL-1 gene cluster are associated with gastroesophageal reflux disease and Barrett’s esophagus. Hum Immunol. 2013;74((9):1161–9.PubMedCrossRef Izakovicova Holla L, Borilova Linhartova P, Hrdlickova B, Marek F, Dolina J, Rihak V, et al. Haplotypes of the IL-1 gene cluster are associated with gastroesophageal reflux disease and Barrett’s esophagus. Hum Immunol. 2013;74((9):1161–9.PubMedCrossRef
24.
Zurück zum Zitat Muramatsu A, Azuma T, Okuda T, Satomi S, Ohtani M, Lee S, et al. Association between interleukin-1beta-511C/T polymorphism and reflux esophagitis in Japan. J Gastroenterol. 2005;40(9):873–7.PubMedCrossRef Muramatsu A, Azuma T, Okuda T, Satomi S, Ohtani M, Lee S, et al. Association between interleukin-1beta-511C/T polymorphism and reflux esophagitis in Japan. J Gastroenterol. 2005;40(9):873–7.PubMedCrossRef
25.
Zurück zum Zitat Queiroz DM, Guerra JB, Rocha GA, Rocha AM, Santos A, De Oliveira AG, et al. IL1B and IL1RN polymorphic genes and Helicobacter pylori cagA strains decrease the risk of reflux esophagitis. Gastroenterology. 2004;127(1):73–9.PubMedCrossRef Queiroz DM, Guerra JB, Rocha GA, Rocha AM, Santos A, De Oliveira AG, et al. IL1B and IL1RN polymorphic genes and Helicobacter pylori cagA strains decrease the risk of reflux esophagitis. Gastroenterology. 2004;127(1):73–9.PubMedCrossRef
26.
Zurück zum Zitat Cheng P, Yalei W, Jianming X. Relationship between gene polymorphisms of IL-1β or IL-1RN and gastroesophageal reflux disease. Acta Universitatis Medicinalis Anhui. 2012;47(4):442–5. Cheng P, Yalei W, Jianming X. Relationship between gene polymorphisms of IL-1β or IL-1RN and gastroesophageal reflux disease. Acta Universitatis Medicinalis Anhui. 2012;47(4):442–5.
27.
Zurück zum Zitat Zhang Y, Li Z. Gastroesophageal reflux disease interleulcins-β1, interleukins-1 receptor antagonist gene polymorphism research. Chin J Diffic Compl Cas. 2013;12(3):194–6. Zhang Y, Li Z. Gastroesophageal reflux disease interleulcins-β1, interleukins-1 receptor antagonist gene polymorphism research. Chin J Diffic Compl Cas. 2013;12(3):194–6.
28.
Zurück zum Zitat Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.PubMedPubMedCentralCrossRef Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.PubMedPubMedCentralCrossRef
29.
Zurück zum Zitat DeVault KRDO. Castell, Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol. 2005;100(1):190–200.PubMedCrossRef DeVault KRDO. Castell, Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol. 2005;100(1):190–200.PubMedCrossRef
30.
Zurück zum Zitat Chong VH, Padam BC, HermantaJ RG. Anand, Gastro-oesophageal reflux disorders among Nepalese residing in Southeast Asia. Med J Malaysia. 2013;68(3):234–8.PubMed Chong VH, Padam BC, HermantaJ RG. Anand, Gastro-oesophageal reflux disorders among Nepalese residing in Southeast Asia. Med J Malaysia. 2013;68(3):234–8.PubMed
31.
Zurück zum Zitat Kandulski AP. Malfertheiner, Gastroesophageal reflux disease–from reflux episodes to mucosal inflammation. Nat Rev Gastroenterol Hepatol. 2012;9(1):15–22.CrossRef Kandulski AP. Malfertheiner, Gastroesophageal reflux disease–from reflux episodes to mucosal inflammation. Nat Rev Gastroenterol Hepatol. 2012;9(1):15–22.CrossRef
32.
Zurück zum Zitat Mansour-Ghanaei F, Joukar F, Atshani SM, ChagharvandF S. Souti, The epidemiology of gastroesophageal reflux disease: a survey on the prevalence and the associated factors in a random sample of the general population in the Northern part of Iran. Int J Mol Epidemiol Genet. 2013;4(3):175–82.PubMedPubMedCentral Mansour-Ghanaei F, Joukar F, Atshani SM, ChagharvandF S. Souti, The epidemiology of gastroesophageal reflux disease: a survey on the prevalence and the associated factors in a random sample of the general population in the Northern part of Iran. Int J Mol Epidemiol Genet. 2013;4(3):175–82.PubMedPubMedCentral
33.
Zurück zum Zitat Ek WE, Levine DM, D’Amato M, Pedersen NL, Magnusson PK, Bresso F, et al. Germline genetic contributions to risk for esophageal adenocarcinoma, Barrett’s esophagus, and gastroesophageal reflux. J Natl Cancer Inst. 2013;105(22):1711–8.PubMedPubMedCentralCrossRef Ek WE, Levine DM, D’Amato M, Pedersen NL, Magnusson PK, Bresso F, et al. Germline genetic contributions to risk for esophageal adenocarcinoma, Barrett’s esophagus, and gastroesophageal reflux. J Natl Cancer Inst. 2013;105(22):1711–8.PubMedPubMedCentralCrossRef
34.
Zurück zum Zitat Steinkasserer A, Spurr NK, Cox S. P. JeggoR.B. Sim, The human IL-1 receptor antagonist gene (IL1RN) maps to chromosome 2q14-q21, in the region of the IL-1 alpha and IL-1 beta loci. Genomics. 1992;13(3):654–7.PubMedCrossRef Steinkasserer A, Spurr NK, Cox S. P. JeggoR.B. Sim, The human IL-1 receptor antagonist gene (IL1RN) maps to chromosome 2q14-q21, in the region of the IL-1 alpha and IL-1 beta loci. Genomics. 1992;13(3):654–7.PubMedCrossRef
Metadaten
Titel
Association of interleukin-1B gene polymorphisms at site 511 with gastroesophageal reflux disease: a meta-analysis
verfasst von
Minmin Xue
Sujuan Zhang
Jia Li
Wei Li
Dongxu Wang
Publikationsdatum
01.01.2016
Verlag
Springer Japan
Erschienen in
Esophagus / Ausgabe 1/2016
Print ISSN: 1612-9059
Elektronische ISSN: 1612-9067
DOI
https://doi.org/10.1007/s10388-015-0498-0

Weitere Artikel der Ausgabe 1/2016

Esophagus 1/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.